Overview

Intrathecal Versus Intravenous Dexmedetomidine in Prostate Transurethral Resection

Status:
Not yet recruiting
Trial end date:
2023-04-29
Target enrollment:
0
Participant gender:
Male
Summary
This study was conducted to compare the effects of intrathecal versus intravenous dexmedetomidine administration in patients undergoing Transurethral resection of the prostate under spinal anesthesia.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Tanta University
Criteria
Inclusion Criteria:

- Cases aged between 50 and 70 years

- Having class I or II according to the American society of anesthesiologists (ASA)

Exclusion Criteria:

- Cases with heart block

- Dysrhythmia

- Contraindications for spinal anesthesia

- Known allergy to the study medications

- Classified as ASA class > II

- Alpha 2 agonist or antagonist therapy.